Physician profile
Chase Dukes
NPI 1518205822
$33,811.49
in general payments reported to CMS, 2019-2025
14 companies · $1,607 in 2025
The $1,607 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $4,750 · 2021: $1,546 · 2022: $23K · 2023: $2,615 · 2024: $340 · 2025: $1,607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,352 · Travel and Lodging: $2,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,351.58 |
| Travel and Lodging | $2,211.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $26,178.42 | 2020-2023 | |
| Zimmer Biomet Holdings, INC. | $2,784.46 | 2021-2025 | Oxford, Rosa |
| Gemini Mountain Medical, LLC | $2,400.00 | 2022 | |
| Stryker Corporation | $1,008.33 | 2020-2025 | Inspace, Alphavent, Cinchlock |
| Medacta USA, INC. | $465.05 | 2022-2024 | Reverse Shoulder |
| Smith+Nephew, INC. | $175.51 | 2021-2023 | Evos |
| Depuy Synthes Sales INC. | $143.28 | 2024 | |
| Breg, INC | $134.96 | 2023 | Breg Vpulse, Plasmaflow, Polarcarewave |
| Fx Shoulder Solutions, INC | $134.02 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $132.28 | 2023 | Iovera, Zilretta |
| Lima USA, INC. | $92.82 | 2023 | Lantern Surgical Assistant, Smr Shoulder |
| Sioux Surgical INC | $77.54 | 2023 | |
| Davol INC. | $49.75 | 2022 | |
| Vericel Corporation | $35.07 | 2022-2024 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chase Dukes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.